Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
Open Access
- 11 July 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (14), 4903
- https://doi.org/10.3390/ijms21144903
Abstract
Recently, the world has been dealing with a devastating global pandemic coronavirus infection, with more than 12 million infected worldwide and over 300,000 deaths as of May 15th 2020, related to a novel coronavirus (2019-nCoV), characterized by a spherical morphology and identified through next-generation sequencing. Although the respiratory tract is the primary portal of entry of SARS-CoV-2, gastrointestinal involvement associated with nausea, vomiting and diarrhoea may also occur. No drug or vaccine has been approved due to the absence of evidence deriving from rigorous clinical trials. Increasing interest has been highlighted on the possible preventative role and adjunct treatment of lactoferrin, glycoprotein of human secretions part of a non-specific defensive system, known to play a crucial role against microbial and viral infections and exerting anti-inflammatory effects on different mucosal surfaces and able to regulate iron metabolism. In this review, analysing lactoferrin properties, we propose designing a clinical trial to evaluate and verify its effect using a dual combination treatment with local, solubilized intranasal spray formulation and oral administration. Lactoferrin could counteract the coronavirus infection and inflammation, acting either as natural barrier of both respiratory and intestinal mucosa or reverting the iron disorders related to the viral colonization.This publication has 107 references indexed in Scilit:
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate ProteoglycansPLOS ONE, 2011
- Antiviral Properties of Lactoferrin—A Natural Immunity MoleculeMolecules, 2011
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Virus Movements on the Plasma Membrane Support Infection and Transmission between CellsPLoS Pathogens, 2009
- The N1 Domain of Human Lactoferrin Is Required for Internalization by Caco-2 Cells and Targeting to the NucleusBiochemistry, 2008
- Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitroInternational Journal of Antimicrobial Agents, 2005
- Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infectionEuropean Journal of Immunology, 2003
- Bovine Lactoferrin Peptidic Fragments Involved in Inhibition of Herpes Simplex Virus Type 1 InfectionBiochemical and Biophysical Research Communications, 1999
- Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cellsAntiviral Research, 1996
- Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthmaJournal of Allergy and Clinical Immunology, 1993